5.19
price up icon1.37%   0.07
after-market Handel nachbörslich: 5.26 0.07 +1.35%
loading

Rocket Pharmaceuticals Inc Aktie (RCKT) Neueste Nachrichten

pulisher
Apr 07, 2025

Rocket Pharmaceuticals appoints new Chief Officer - Investing.com

Apr 07, 2025
pulisher
Apr 03, 2025

Rocket Pharmaceuticals to Participate in the 24th Annual Needham Virtual Healthcare Conference - BioSpace

Apr 03, 2025
pulisher
Apr 03, 2025

Thrivent Financial for Lutherans Sells 21,731 Shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - Defense World

Apr 03, 2025
pulisher
Apr 02, 2025

Is Rocket Pharmaceuticals Inc. (NASDAQ:RCKT) the Best US Stock Under $10 to Buy Right Now? - MSN

Apr 02, 2025
pulisher
Apr 02, 2025

Where are the Opportunities in (RCKT) - news.stocktradersdaily.com

Apr 02, 2025
pulisher
Apr 02, 2025

Teacher Retirement System of Texas Raises Holdings in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - Defense World

Apr 02, 2025
pulisher
Mar 30, 2025

Rocket Pharmaceuticals (NASDAQ:RCKT) Reaches New 1-Year LowHere's Why - MarketBeat

Mar 30, 2025
pulisher
Mar 29, 2025

Swiss National Bank Has $1.93 Million Position in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - Defense World

Mar 29, 2025
pulisher
Mar 24, 2025

Rocket Pharmaceuticals’ SWOT analysis: gene therapy stock poised for growth amid challenges By Investing.com - Investing.com South Africa

Mar 24, 2025
pulisher
Mar 24, 2025

Rocket Pharmaceuticals’ SWOT analysis: gene therapy stock poised for growth amid challenges - Investing.com India

Mar 24, 2025
pulisher
Mar 24, 2025

Cantor Fitzgerald maintains Overweight on Rocket Pharmaceuticals stock By Investing.com - Investing.com Canada

Mar 24, 2025
pulisher
Mar 24, 2025

Charles Schwab Investment Management Inc. Has $8.25 Million Position in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - Defense World

Mar 24, 2025
pulisher
Mar 22, 2025

(RCKT) Technical Pivots with Risk Controls - news.stocktradersdaily.com

Mar 22, 2025
pulisher
Mar 22, 2025

PNC Financial Services Group Inc. Increases Stock Position in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - Defense World

Mar 22, 2025
pulisher
Mar 21, 2025

Bank of New York Mellon Corp Buys 9,949 Shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - Defense World

Mar 21, 2025
pulisher
Mar 20, 2025

Fanconi Anemia Pipeline 2025: FDA Approvals and Clinical Trials - openPR.com

Mar 20, 2025
pulisher
Mar 19, 2025

What technical indicators reveal about RCKT stock - US Post News

Mar 19, 2025
pulisher
Mar 18, 2025

Steward Partners Investment Advisory LLC Has $84,000 Stock Position in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - Defense World

Mar 18, 2025
pulisher
Mar 16, 2025

Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Shares Purchased by Arizona State Retirement System - Defense World

Mar 16, 2025
pulisher
Mar 14, 2025

BMO Capital Markets Begins Coverage on Rocket Pharmaceuticals (NASDAQ:RCKT) - Defense World

Mar 14, 2025
pulisher
Mar 14, 2025

Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Receives Average Rating of “Moderate Buy” from Brokerages - Defense World

Mar 14, 2025
pulisher
Mar 12, 2025

(RCKT) Investment Analysis and Advice - news.stocktradersdaily.com

Mar 12, 2025
pulisher
Mar 12, 2025

BMO Capital Initiates Coverage on Rocket Pharmaceuticals With Outperform Rating, $50 Price Target - Marketscreener.com

Mar 12, 2025
pulisher
Mar 12, 2025

BMO Capital Initiates Coverage of Rocket Pharmaceuticals (RCKT) with Outperform Recommendation - Nasdaq

Mar 12, 2025
pulisher
Mar 12, 2025

Rocket Pharmaceuticals: A Buy Rating for Its Pioneering Gene Therapy Approach and Promising Pipeline - TipRanks

Mar 12, 2025
pulisher
Mar 12, 2025

BMO Capital sets $50 target for Rocket Pharmaceuticals stock - Investing.com India

Mar 12, 2025
pulisher
Mar 11, 2025

BMO Capital sets $50 target for Rocket Pharmaceuticals stock By Investing.com - Investing.com Canada

Mar 11, 2025
pulisher
Mar 11, 2025

RCKT stock touches 52-week low at $8.22 amid market challenges - Investing.com

Mar 11, 2025
pulisher
Mar 08, 2025

Private Advisor Group LLC Acquires Shares of 13,199 Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - Defense World

Mar 08, 2025
pulisher
Mar 06, 2025

Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Shares Sold by New York State Common Retirement Fund - Defense World

Mar 06, 2025
pulisher
Mar 06, 2025

Rhumbline Advisers Has $1.25 Million Stock Position in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - Defense World

Mar 06, 2025
pulisher
Mar 06, 2025

Research Analysts Set Expectations for RCKT FY2025 Earnings - Defense World

Mar 06, 2025
pulisher
Mar 05, 2025

Rocket Pharmaceuticals, Inc. (RCKT): A Bull Case Theory - Insider Monkey

Mar 05, 2025
pulisher
Mar 04, 2025

2025 Market Prospects of Adeno-Associated Virus Vectors in Gene Therapy Pipeline: 200 Pipeline Drugs and the Strategic Workings of 180+ Companies - GlobeNewswire Inc.

Mar 04, 2025
pulisher
Mar 04, 2025

Handelsbanken Fonder AB Has $290,000 Stock Position in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - Defense World

Mar 04, 2025
pulisher
Mar 04, 2025

Rocket Pharmaceuticals (NASDAQ:RCKT) Price Target Cut to $15.00 by Analysts at The Goldman Sachs Group - Defense World

Mar 04, 2025
pulisher
Mar 04, 2025

Rocket Pharmaceuticals (NASDAQ:RCKT) Price Target Raised to $52.00 at Scotiabank - Defense World

Mar 04, 2025
pulisher
Mar 04, 2025

Rocket Pharmaceuticals (NASDAQ:RCKT) Price Target Lowered to $36.00 at Canaccord Genuity Group - Defense World

Mar 04, 2025
pulisher
Mar 04, 2025

Rocket Pharmaceuticals (NASDAQ:RCKT) Sets New 1-Year Low on Analyst Downgrade - Defense World

Mar 04, 2025
pulisher
Mar 03, 2025

Rocket Pharmaceuticals Inc (NASDAQ: RCKT)’s Stock Adds 0.53%, Making It A Good Investment - Stocks Register

Mar 03, 2025
pulisher
Mar 03, 2025

Scotiabank raises Rocket Pharmaceuticals target to $52 - Investing.com

Mar 03, 2025
pulisher
Mar 03, 2025

What is William Blair’s Estimate for RCKT Q1 Earnings? - Defense World

Mar 03, 2025
pulisher
Mar 03, 2025

What is Leerink Partnrs’ Estimate for RCKT Q2 Earnings? - Defense World

Mar 03, 2025
pulisher
Mar 03, 2025

Chardan Capital Cuts Rocket Pharmaceuticals (NASDAQ:RCKT) Price Target to $54.00 - Defense World

Mar 03, 2025
pulisher
Mar 03, 2025

Needham & Company LLC Cuts Rocket Pharmaceuticals (NASDAQ:RCKT) Price Target to $42.00 - Defense World

Mar 03, 2025
pulisher
Mar 02, 2025

Rocket Pharmaceuticals price target lowered to $15 from $29 at Goldman Sachs - MSN

Mar 02, 2025
pulisher
Mar 02, 2025

When Will Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Turn A Profit? - Yahoo Finance Australia

Mar 02, 2025
pulisher
Mar 01, 2025

Decoding Rocket Pharmaceuticals Inc (RCKT): A Strategic SWOT Ins - GuruFocus

Mar 01, 2025
pulisher
Mar 01, 2025

Rocket Pharmaceuticals Q4 Loss Narrower Than Estimates, Pipeline in Focus - MSN

Mar 01, 2025
pulisher
Feb 28, 2025

Rocket Pharmaceuticals Advances Gene Therapy Pipeline - TipRanks

Feb 28, 2025
pulisher
Feb 28, 2025

Rocket Pharmaceuticals (NASDAQ:RCKT) Posts Earnings Results, Beats Estimates By $0.06 EPS - MarketBeat

Feb 28, 2025
$60.29
price down icon 0.48%
$68.09
price down icon 1.58%
$17.32
price down icon 0.23%
$31.03
price down icon 0.26%
$86.82
price down icon 1.40%
biotechnology ONC
$220.54
price down icon 7.53%
Kapitalisierung:     |  Volumen (24h):